Green Thumb Industries Inc.
General ticker "GTBIF" information:
- Sector: Health Care
- Industry: Pharmaceuticals
- Capitalization: $1.6B (TTM average)
Green Thumb Industries Inc. follows the US Stock Market performance with the rate: 32.0%.
Estimated limits based on current volatility of 4.8%: low 6.25$, high 6.87$
Factors to consider:
- Total employees count: 4800 (+4.3%) as of 2024
- Company does not operate outside US (retrieved using AI)
- Top business risk factors: Economic downturns and volatility, Regulatory and compliance, Product liability, Cybersecurity threats, Market competition
- Price in estimated range
- Earnings for 9 months up through Q3 are below our estimates
Stock Forecast*
* forecast is subjective and experimental, should not be used for any investment decisions
Long term estimates were made for the period from 2024-12-31 to 2026-12-31
- 2024-12-31 to 2025-12-31 estimated range: [3.44$, 8.56$]
- 2025-12-31 to 2026-12-31 estimated range: [2.53$, 6.36$]
Financial Metrics affecting the GTBIF estimates:
- Positive: with PPE of 26.2 at the end of fiscal year the price was very low
- Positive: Operating profit margin, % of 19.74 > 18.64
- Negative: negative Industry operating cash flow (median)
- Negative: 0.79 < Interest expense per share per price, % of 1.30
- Negative: Investing cash flow per share per price, % of -4.81 <= -4.48
- Negative: Industry earnings per price (median), % of 0 <= 0
- Negative: negative Industry operating income (median)
- Positive: Shareholder equity ratio, % of 70.53 > 63.39
Short-term GTBIF quotes
Long-term GTBIF plot with estimates
Financial data
| YTD | 2022-12-31 | 2023-12-31 | 2024-12-31 |
|---|---|---|---|
| Operating Revenue | $1,017.38MM | $1,054.55MM | $1,137.14MM |
| Operating Expenses | $896.31MM | $869.92MM | $912.72MM |
| Operating Income | $121.06MM | $184.63MM | $224.43MM |
| Non-Operating Income | $-12.63MM | $-28.58MM | $-24.29MM |
| Interest Expense | $21.20MM | $19.07MM | $24.27MM |
| Income(Loss) | $108.43MM | $156.05MM | $200.14MM |
| Taxes | $94.78MM | $118.63MM | $126.29MM |
| Profit(Loss)* | $11.98MM | $36.27MM | $73.08MM |
| Stockholders Equity | $1,664.92MM | $1,702.88MM | $1,789.28MM |
| Inventory | $115.67MM | $112.97MM | $147.16MM |
| Assets | $2,433.53MM | $2,490.06MM | $2,537.01MM |
| Operating Cash Flow | $158.56MM | $224.97MM | $195.18MM |
| Capital expenditure | $179.50MM | $220.03MM | $80.19MM |
| Investing Cash Flow | $-219.95MM | $-227.91MM | $-89.54MM |
| Financing Cash Flow | $8.64MM | $-13.11MM | $-95.59MM |
| Earnings Per Share** | $0.05 | $0.15 | $0.31 |
* Profit(Loss) attributable to entity.
** EPS are Split Adjusted, recent splits may be reflected with a delay.